677 related articles for article (PubMed ID: 14607197)
1. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
4. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
5. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
[TBL] [Abstract][Full Text] [Related]
6. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
[TBL] [Abstract][Full Text] [Related]
7. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
8. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of heart failure using urinary natriuretic peptides.
Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
[TBL] [Abstract][Full Text] [Related]
10. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
11. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography.
Ng LL; Loke I; Davies JE; Khunti K; Stone M; Abrams KR; Chin DT; Squire IB
Eur J Heart Fail; 2003 Dec; 5(6):775-82. PubMed ID: 14675856
[TBL] [Abstract][Full Text] [Related]
12. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
13. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
Vasan RS; Benjamin EJ; Larson MG; Leip EP; Wang TJ; Wilson PW; Levy D
JAMA; 2002 Sep; 288(10):1252-9. PubMed ID: 12215132
[TBL] [Abstract][Full Text] [Related]
14. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Falcão LM; Pinto F; Ravara L; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic potential of cardiac natriuretic peptides in dialysis patients.
Mallamaci F; Zoccali C; Tripepi G; Benedetto FA; Parlongo S; Cataliotti A; Cutrupi S; Giacone G; Bellanuova I; Stancanelli B; Malatino LS;
Kidney Int; 2001 Apr; 59(4):1559-66. PubMed ID: 11260421
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
17. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
18. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
19. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
Bakowski D; Wozakowska-Kaplon B; Opolski G
Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
[TBL] [Abstract][Full Text] [Related]
20. Biochemical detection of left-ventricular systolic dysfunction.
McDonagh TA; Robb SD; Murdoch DR; Morton JJ; Ford I; Morrison CE; Tunstall-Pedoe H; McMurray JJ; Dargie HJ
Lancet; 1998 Jan; 351(9095):9-13. PubMed ID: 9433422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
